Publication:
Surgical Technology International XVII - Wound Healing
Article title:
Current Management of Venous Ulcers: An Evidence-Based Review
Order Article:

Reprint Copies:  500 - $1,960.00

1000 - $3,720.00

By e-mail: PDF Format - $69.00

 

Author(s)

Jordana Herschthal, B.A.

Department of Dermatology and Cutaneous Surgery

 

Robert S. Kirsner, M.D., Ph.D.
Vice-Chairman and The Stiefel Laboratories Professor of Medical Dermatology

Department of Dermatology and Cutaneous Surgery, Department of Epidemiology and Public Health

 

Miller School of Medicine, University of Miami, Miami, Florida, USA

Abstract
Chronic venous ulceration is a common and important medical problem that causes significant morbidity. Venous ulcers are expensive to treat, have substantial economic effects in terms of days of work lost, and adversely impact the patient's quality of life. Relying on evidence allows for a rationale of clinical decision making. The objectives of venous ulcer management include the healing of the ulcer, prevention of recurrence, and improvement of edema. Compression is the cornerstone of venous ulcer therapy. Adjunctive modalities such as surgery, growth factors, grafting, biologic skin substitutes, dressings, and oral medication have differing levels of evidence supporting their use, and may also facilitate the healing process.

 

 

 

 

 

 

 

 

 

Products featured in the Article:

 

Apligraf®
BioSeed®
Co-Plus®
Daflon®
Elastocrepe®
Oasis®
Orcel®
Profore®
Setopress®
Soffban®
Soffcrepe®
Sotradecol®
Tricotex®
UrgoCell®